Why Did Annovis Bio (ANVS) Stock Close Up 80% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

ANVS stock closed up more than 75% today after Annovis announced encouraging clinical trial results for its Parkinson's drug, buntanetap.

The post Why Did Annovis Bio (ANVS) Stock Close Up 80% Today? appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”